Analysis of Potential Genotoxic Impurities in Active Pharmaceutical Ingredients

Methanesulfonic acid (mesylate), benzenesulfonic acid (besilate), and p-toluenesulfonic acid (tosylate), chemicals used in the process of synthesizing active pharmaceutical ingredients, are likely to generate sulfonic acid ester (Fig. 1) as a reaction byproduct. These compounds are known as potential genotoxic impurities (PGI) and are a significant cause for concern among pharmaceutical manufacturers. This article introduces the analysis of sulfonic acid esters utilizing the GCMS-QP2010 Ultra.

Content Type:
Application
Document Number:
LAAN-J-MS-E018
Product Type:
Mass Spectrometry, Gas Chromatograph-Mass Spectrometry
Keywords:
Potential Genotoxic Impurities, Pharmaceutical, Life Science, Drug discovery, DMPK, ADME, Safety testing, GCMS-QP2010 Ultra
Language:
English
File Name:
jpo212073.pdf
File Size:
134kb

View Article

For Research Use Only. Not for use in diagnostic procedures.

This page may contain references to products that are not available in your country. Please contact us to check the availability of these products in your country.

Top of This Page